BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 29417701)

  • 1. Impact of novel oncogenic pathways regulated by antitumor miR-451a in renal cell carcinoma.
    Yamada Y; Arai T; Sugawara S; Okato A; Kato M; Kojima S; Yamazaki K; Naya Y; Ichikawa T; Seki N
    Cancer Sci; 2018 Apr; 109(4):1239-1253. PubMed ID: 29417701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of antitumor miR-144-5p targets oncogenes: Direct regulation of syndecan-3 and its clinical significance.
    Yamada Y; Arai T; Kojima S; Sugawara S; Kato M; Okato A; Yamazaki K; Naya Y; Ichikawa T; Seki N
    Cancer Sci; 2018 Sep; 109(9):2919-2936. PubMed ID: 29968393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of spindle and kinetochore-associated protein 1 by antitumor miR-10a-5p in renal cell carcinoma.
    Arai T; Okato A; Kojima S; Idichi T; Koshizuka K; Kurozumi A; Kato M; Yamazaki K; Ishida Y; Naya Y; Ichikawa T; Seki N
    Cancer Sci; 2017 Oct; 108(10):2088-2101. PubMed ID: 28746769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor suppressive microRNA-1285 regulates novel molecular targets: aberrant expression and functional significance in renal cell carcinoma.
    Hidaka H; Seki N; Yoshino H; Yamasaki T; Yamada Y; Nohata N; Fuse M; Nakagawa M; Enokida H
    Oncotarget; 2012 Jan; 3(1):44-57. PubMed ID: 22294552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epithelial-mesenchymal transition-related microRNA-200s regulate molecular targets and pathways in renal cell carcinoma.
    Yoshino H; Enokida H; Itesako T; Tatarano S; Kinoshita T; Fuse M; Kojima S; Nakagawa M; Seki N
    J Hum Genet; 2013 Aug; 58(8):508-16. PubMed ID: 23635949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual Strands of Pre-miR-149 Inhibit Cancer Cell Migration and Invasion through Targeting FOXM1 in Renal Cell Carcinoma.
    Okato A; Arai T; Yamada Y; Sugawara S; Koshizuka K; Fujimura L; Kurozumi A; Kato M; Kojima S; Naya Y; Ichikawa T; Seki N
    Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28902136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-218 inhibits cell migration and invasion in renal cell carcinoma through targeting caveolin-2 involved in focal adhesion pathway.
    Yamasaki T; Seki N; Yoshino H; Itesako T; Hidaka H; Yamada Y; Tatarano S; Yonezawa T; Kinoshita T; Nakagawa M; Enokida H
    J Urol; 2013 Sep; 190(3):1059-68. PubMed ID: 23454155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of the collagen cross-linking enzymes LOXL2 and PLOD2 by tumor-suppressive microRNA-26a/b in renal cell carcinoma.
    Kurozumi A; Kato M; Goto Y; Matsushita R; Nishikawa R; Okato A; Fukumoto I; Ichikawa T; Seki N
    Int J Oncol; 2016 May; 48(5):1837-46. PubMed ID: 26983694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular pathogenesis of renal cell carcinoma: Impact of the anti-tumor miR-29 family on gene regulation.
    Yamada Y; Sugawara S; Arai T; Kojima S; Kato M; Okato A; Yamazaki K; Naya Y; Ichikawa T; Seki N
    Int J Urol; 2018 Nov; 25(11):953-965. PubMed ID: 30153702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-suppressive microRNA-135a inhibits cancer cell proliferation by targeting the c-MYC oncogene in renal cell carcinoma.
    Yamada Y; Hidaka H; Seki N; Yoshino H; Yamasaki T; Itesako T; Nakagawa M; Enokida H
    Cancer Sci; 2013 Mar; 104(3):304-12. PubMed ID: 23176581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel circRNA, circNUP98, a potential biomarker, acted as an oncogene via the miR-567/ PRDX3 axis in renal cell carcinoma.
    Yu R; Yao J; Ren Y
    J Cell Mol Med; 2020 Sep; 24(17):10177-10188. PubMed ID: 32729669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-suppressive microRNA-1291 directly regulates glucose transporter 1 in renal cell carcinoma.
    Yamasaki T; Seki N; Yoshino H; Itesako T; Yamada Y; Tatarano S; Hidaka H; Yonezawa T; Nakagawa M; Enokida H
    Cancer Sci; 2013 Nov; 104(11):1411-9. PubMed ID: 23889809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-106b functions as an oncogene in renal cell carcinoma by affecting cell proliferation, migration and apoptosis.
    Li Y; Chen D; Su Z; Li Y; Liu J; Jin L; Shi M; Jiang Z; Qi Z; Gui Y; Yang S; Mao X; Wu X; Lai Y
    Mol Med Rep; 2016 Feb; 13(2):1420-6. PubMed ID: 26648244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. microRNA-200c modulates the epithelial-to-mesenchymal transition in human renal cell carcinoma metastasis.
    Wang X; Chen X; Wang R; Xiao P; Xu Z; Chen L; Hang W; Ruan A; Yang H; Zhang X
    Oncol Rep; 2013 Aug; 30(2):643-50. PubMed ID: 23754305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-192, miR-194 and miR-215: a convergent microRNA network suppressing tumor progression in renal cell carcinoma.
    Khella HW; Bakhet M; Allo G; Jewett MA; Girgis AH; Latif A; Girgis H; Von Both I; Bjarnason GA; Yousef GM
    Carcinogenesis; 2013 Oct; 34(10):2231-9. PubMed ID: 23715501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circular RNA circ_001842 plays an oncogenic role in renal cell carcinoma by disrupting microRNA-502-5p-mediated inhibition of SLC39A14.
    Zeng J; Feng Q; Wang Y; Xie G; Li Y; Yang Y; Feng J
    J Cell Mol Med; 2020 Sep; 24(17):9712-9725. PubMed ID: 32729666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-203 inhibition of renal cancer cell proliferation, migration and invasion by targeting of FGF2.
    Xu M; Gu M; Zhang K; Zhou J; Wang Z; Da J
    Diagn Pathol; 2015 Apr; 10():24. PubMed ID: 25890121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. microRNA-133b downregulation and inhibition of cell proliferation, migration and invasion by targeting matrix metallopeptidase-9 in renal cell carcinoma.
    Wu D; Pan H; Zhou Y; Zhou J; Fan Y; Qu P
    Mol Med Rep; 2014 Jun; 9(6):2491-8. PubMed ID: 24714873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-suppressive microRNA-143/145 cluster targets hexokinase-2 in renal cell carcinoma.
    Yoshino H; Enokida H; Itesako T; Kojima S; Kinoshita T; Tatarano S; Chiyomaru T; Nakagawa M; Seki N
    Cancer Sci; 2013 Dec; 104(12):1567-74. PubMed ID: 24033605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-1293 Suppresses Tumor Malignancy by Targeting Hydrocyanic Oxidase 2: Therapeutic Potential of a miR-1293/Hydrocyanic Oxidase 2 Axis in Renal Cell Carcinoma.
    Liu XL; Pan WG; Li KL; Mao YJ; Liu SD; Zhang RM
    Cancer Biother Radiopharm; 2020 Jun; 35(5):377-386. PubMed ID: 31971830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.